“GOLD E” VERSUS “FREQUENT EXACERBATOR” CLASSIFICATIONS IN COPD: A PROTEO-METABOLOMIC PERSPECTIVE. [COMUNICACIÓN PREMIADA]
Introduction: COPD treatment is often guided by the GOLD E phenotype (≥1 hospitalization or >1 exacerbation/prior year) versus GOLD AB. Alternatively, frequent exacerbators (FE) are defined as ≥3 exacerbations/year, regardless of hospitalization. Their biological basis requires exploration by omics...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2026-02-01
|
| Sarja: | Open Respiratory Archives |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S2659663626000111 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
